Condition class · subcategory · California
Growth Horm Def denials at external review
When a California health plan denied care for growth horm def and the enrollee took it to Independent Medical Review, this is what independent physician reviewers decided.
56.4%
- Overturned
- 22 of 39
- Era
- 2021-2025
- Jurisdiction
- California DMHC IMR
- Published class
- Growth Horm Def
- Median days to decision
- 41
- All years
- 40.9% of 313
Authorities named in this class
computed- FDA—20
- National Institutes of Health—1
A rate here is the outcome of decisions that named the authority, not the effect of naming it. Reviewers cite the standard they applied; the citation and the outcome share a cause.
By treatment
computed- Overturned — the reviewer did not sustain the denial
- Upheld — the reviewer sustained the denial
- Pharmacy55.3%38
- Diagnostic imaging & screening—1
The specific treatments inside this class
below n=30, no rate is claimed- Hormones55.3%38
- Lab Work—1
Every figure on this page is conditional on a denial having reached external review. Fewer than 1% of denials are appealed internally at all, so this describes denials that were fought to the end — not denials in general — and it describes California only. Who this does not cover.
Free help, first: the California DMHC Help Center files your Independent Medical Review at no cost — 1-888-466-2219, dmhc.ca.gov.